Multiplex Microsphere PCR (mmPCR) Allows Simultaneous Gram Typing, Detection of Fungal DNA, and Antibiotic Resistance Genes.


Journal

Laboratory medicine
ISSN: 1943-7730
Titre abrégé: Lab Med
Pays: England
ID NLM: 0250641

Informations de publication

Date de publication:
01 Sep 2022
Historique:
pubmed: 24 4 2022
medline: 8 9 2022
entrez: 23 4 2022
Statut: ppublish

Résumé

To show the high analytical specificity of our multiplex microsphere polymerase chain reaction (mmPCR) method, which offers the simultaneous detection of both general (eg, Gram type) and specific (eg, Pseudomonas species) clinically relevant genetic targets in a single modular multiplex reaction. Isolated gDNA of 16S/rRNA Sanger-sequenced and Basic Local Alignment Tool-identified bacterial and fungal isolates were selectively amplified in a custom 10-plex Luminex MagPlex-TAG microsphere-based mmPCR assay. The signal/noise ratio for each reaction was calculated from flow cytometry standard data collected on a BD LSR Fortessa II flow cytometer. Data were normalized to the no-template negative control and the signal maximum. The analytical specificity of the assay was compared to single-plex SYBR chemistry quantitative PCR. Both general and specific primer sets were functional in the 10-plex mmPCR. The general Gram typing and pan-fungal primers correctly identified all bacterial and fungal isolates, respectively. The species-specific and antibiotic resistance-specific primers correctly identified the species- and resistance-carrying isolates, respectively. Low-level cross-reactive signals were present in some reactions with high signal/noise primer ratios. We found that mmPCR can simultaneously detect specific and general clinically relevant genetic targets in multiplex. These results serve as a proof-of-concept advance that highlights the potential of high multiplex mmPCR diagnostics in clinical practice. Further development of specimen-specific DNA extraction techniques is required for sensitivity testing.

Identifiants

pubmed: 35460243
pii: 6572827
doi: 10.1093/labmed/lmac023
pmc: PMC9435484
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA Primers 0
DNA, Fungal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-464

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Prestige Research Training Program
Organisme : Queensland Health Junior Clinical Research Fellowship

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of American Society for Clinical Pathology.

Références

Curr Opin Microbiol. 2012 Oct;15(5):577-82
pubmed: 22954750
Anal Biochem. 2012 Mar 15;422(2):89-95
pubmed: 22266293
Transfusion. 2017 Mar;57(3pt2):734-747
pubmed: 28194799
Nat Rev Microbiol. 2020 May;18(5):299-311
pubmed: 32055026
Biotechnol Adv. 2019 May - Jun;37(3):476-490
pubmed: 30797092
ACS Infect Dis. 2018 May 11;4(5):837-844
pubmed: 29350524
Biochem Mol Biol Educ. 2011 Mar-Apr;39(2):145-54
pubmed: 21445907
Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1333-1344
pubmed: 29700761
Ann Intern Med. 1997 Jan 1;126(1):91-4
pubmed: 8992938
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1829-1836
pubmed: 31243596
Front Immunol. 2020 Mar 20;11:402
pubmed: 32265908
Curr Microbiol. 2014 Feb;68(2):149-55
pubmed: 24026449
Int J Infect Dis. 2011 May;15(5):e326-31
pubmed: 21353616
Clin Microbiol Rev. 2018 Feb 28;31(2):
pubmed: 29490932
PLoS One. 2013 Aug 15;8(8):e72349
pubmed: 23977288
Clin Infect Dis. 2018 Feb 10;66(5):778-788
pubmed: 29040428
Anal Biochem. 2013 Jan 1;432(1):23-30
pubmed: 23000310
Cytometry A. 2011 Sep;79(9):713-9
pubmed: 21786420

Auteurs

Daniel J Browne (DJ)

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns,Australia.

Fang Liang (F)

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Kate H Gartlan (KH)

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
School of Medicine, University of Queensland, Brisbane, Australia.

Patrick N A Harris (PNA)

Faculty of Medicine, UQ Centre for Clinical Research, University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia.

Geoffrey R Hill (GR)

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Division of Hematopoietic Transplantation, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Simon R Corrie (SR)

Department of Chemical Engineering, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash and QLD Nodes, Monash University, Clayton, Australia.

Kate A Markey (KA)

Division of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
School of Medicine, University of Queensland, Brisbane, Australia.
Division of Hematopoietic Transplantation, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH